DK0749969T3 - Fremgangsmåde til fremstilling af polymorf form I af d4T - Google Patents

Fremgangsmåde til fremstilling af polymorf form I af d4T

Info

Publication number
DK0749969T3
DK0749969T3 DK96304030T DK96304030T DK0749969T3 DK 0749969 T3 DK0749969 T3 DK 0749969T3 DK 96304030 T DK96304030 T DK 96304030T DK 96304030 T DK96304030 T DK 96304030T DK 0749969 T3 DK0749969 T3 DK 0749969T3
Authority
DK
Denmark
Prior art keywords
polymorphic form
preparing polymorphic
preparing
approved
aids
Prior art date
Application number
DK96304030T
Other languages
Danish (da)
English (en)
Inventor
Murray Arthur Kaplan
Rajesh Babulal Gandhi
Joseph Ballard Bogardus
Peter Michael Garofalo
Timothy Richard Marr
Robert Kevin Perrone
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0749969T3 publication Critical patent/DK0749969T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK96304030T 1995-06-05 1996-06-04 Fremgangsmåde til fremstilling af polymorf form I af d4T DK0749969T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/465,208 US5608048A (en) 1995-06-05 1995-06-05 d4 T polymorphic Form 1 process

Publications (1)

Publication Number Publication Date
DK0749969T3 true DK0749969T3 (da) 2001-11-26

Family

ID=23846880

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96304030T DK0749969T3 (da) 1995-06-05 1996-06-04 Fremgangsmåde til fremstilling af polymorf form I af d4T

Country Status (19)

Country Link
US (1) US5608048A (es)
EP (1) EP0749969B1 (es)
JP (1) JP4208976B2 (es)
KR (1) KR100375957B1 (es)
CN (1) CN1058723C (es)
AT (1) ATE205203T1 (es)
AU (1) AU694653B2 (es)
CA (1) CA2176181C (es)
DE (1) DE69614936T2 (es)
DK (1) DK0749969T3 (es)
ES (1) ES2160768T3 (es)
GR (1) GR3036768T3 (es)
HK (1) HK1003435A1 (es)
HU (1) HU222285B1 (es)
IL (1) IL118527A (es)
MX (1) MX9601957A (es)
PT (1) PT749969E (es)
SG (1) SG43372A1 (es)
TW (1) TW336937B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002020538A2 (en) * 2000-09-06 2002-03-14 Bristol-Myers Squibb Company Stavudine polymorphic form 1 process
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
WO2007099389A1 (en) * 2005-07-11 2007-09-07 Aurobindo Pharma Limited A new improved process for the preparation of stavudine form i
ITMI20060360A1 (it) * 2006-02-28 2007-09-01 Clariant Lsm Italia Spa Novel method for the preparation of stavudine polymorphic form 1 and form ii
JP5966186B2 (ja) * 2011-02-08 2016-08-10 国立大学法人高知大学 カルサイト単結晶の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4904770A (en) * 1988-03-24 1990-02-27 Bristol-Myers Company Production of 2',3'-dideoxy-2',3'-didehydronucleosides
US5539099A (en) * 1993-11-15 1996-07-23 Bristol-Myers Squibb Company Process for large-scale preparation of 2',3'-didehydro-2',3'-dideoxynucleosides
US5672698A (en) * 1993-11-15 1997-09-30 Bristol-Myers Squibb Co. Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine
US5608049A (en) * 1995-03-10 1997-03-04 Bristol-Myers Squibb Company Preparation of d4T from 5-methyluridine

Also Published As

Publication number Publication date
EP0749969B1 (en) 2001-09-05
ES2160768T3 (es) 2001-11-16
PT749969E (pt) 2001-12-28
HK1003435A1 (en) 1998-10-30
EP0749969A3 (en) 1997-03-19
CA2176181C (en) 2007-03-13
GR3036768T3 (en) 2002-01-31
AU694653B2 (en) 1998-07-23
AU5469296A (en) 1996-12-19
HU222285B1 (hu) 2003-05-28
DE69614936T2 (de) 2002-04-25
EP0749969A2 (en) 1996-12-27
ATE205203T1 (de) 2001-09-15
MX9601957A (es) 1997-08-30
JP4208976B2 (ja) 2009-01-14
IL118527A0 (en) 1996-10-16
HUP9601517A3 (en) 2000-03-28
US5608048A (en) 1997-03-04
TW336937B (en) 1998-07-21
SG43372A1 (en) 1997-10-17
HUP9601517A2 (en) 1997-05-28
HU9601517D0 (en) 1996-07-29
IL118527A (en) 2000-07-16
JPH08333364A (ja) 1996-12-17
KR970001369A (ko) 1997-01-24
CA2176181A1 (en) 1996-12-06
CN1058723C (zh) 2000-11-22
CN1145903A (zh) 1997-03-26
DE69614936D1 (de) 2001-10-11
KR100375957B1 (ko) 2003-12-31

Similar Documents

Publication Publication Date Title
DK1787980T3 (da) Krystallint og rent modafinil og fremgangsmåde til atfremstille dette
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
FI971609A (fi) Menetelmä 4a,5,9,10,11,12-heksahydro-6H-bentsofuro-(3a,3,2-ef)(2)-bentsatsepiinijohdannaisten valmistamiseksi
ES2163638T3 (es) Nuevas n-(1-alquil-5-fenil-2,3,4,5-tetrahidro-1h-benzo(b)(1,5)diacepin-3-il)acetamidas.
DK503082A (da) Fremgangsmaade til fremstilling af 3-(1-substitueret-4-piperidyl)-1,2-benzisoxazoler
NZ228065A (en) 1,2,4-triazinediones and parasiticidal compositions; processes for preparation
DK0749969T3 (da) Fremgangsmåde til fremstilling af polymorf form I af d4T
DK0785949T3 (da) Fremgangsmåde til oprensning af keratinocytvækstfaktorer
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
DK0968997T3 (da) Fremgangsmåde til fremstilling af S-aryl-L-cystein og derivater
NO903338L (no) Fremgangsmaate for mikrobiologisk fremstilling av l-carnitin.
ATE181556T1 (de) Darstellung von d4t aus 5-methyluridin
TR200101084T2 (tr) Antineoplastik maddeler üretmeye mahsus stereoselektif yöntem
DE69616801D1 (de) Eintopfverfahren zur herstellung von 2-oxazolidinonderivate
DE59904904D1 (de) Verfahren zur Herstellung von Phenyldichloro-1,3,5-triazinverbindungen
DK0783491T3 (da) Fremgangsmåde til fremstilling af 3,3,5-trichlorglutarimid
DK0662474T3 (da) Fremgangsmåde til fremstilling af chlorpyridiner
DK93884D0 (da) Fremgangsmade til fremstilling af 1,5-dibeskyttede-1,5,10-triazadecaner, mellemprodukter derfor samt disses fremstilling
DE69608512D1 (de) Verfahren zur Herstellung von benzylsubstituierten Rhodaninederivaten
DE59101666D1 (de) Vorrichtung zur Längsverstellung von Fersenhaltern.